Patent details

EP1550722 Title: Recombinant human adenovirus serotype 35

Basic Information

Publication number:
EP1550722
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP040774341
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Recombinant human adenovirus serotype 35
French Title of Invention:
Adénovirus humain type 35 recombinant
German Title of Invention:
Rekombinanter humaner Adenovirus-Serotyp 35
SPC Number:

Dates

Filing date:
16/05/2000
Grant date:
13/06/2007
EP Publication Date:
13/06/2007
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/07/2005
EP B1 Publication Date:
13/06/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/05/2015
Expiration date:
16/05/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/05/2000
 
 

Name:
Crucell Holland B.V.
Address:
Archimedesweg 4, 2333 CN Leiden, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/07/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Bout Abraham
Address:
Netherlands (NL)

2

Name:
Havenga Menzo Jans Emco
Address:
Netherlands (NL)

3

Name:
Vogels Ronald
Address:
Netherlands (NL)

Priority

Priority Number:
99201545
Priority Date:
17/05/1999
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C12N 15/86;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages